| adrenergic receptor, alpha 1b |
OXYMETAZOLINE |
Adrenergic alpha1B |
88% |
1.245uM |
.689uM |
View
|
| epidermal growth factor receptor |
EBASTINE |
Protein Tyrosine Kinase, EGF Receptor |
88% |
.5591uM |
NoneNone |
View
|
| dopamine receptor D4 |
EBASTINE |
Dopamine D4.2 |
88% |
1.2996uM |
.4557uM |
View
|
| 5-hydroxytryptamine receptor 6 |
ORPHENADRINE |
Serotonin 5-HT6 |
88% |
1.121uM |
.521uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
CETYLPYRIDINIUM BROMIDE |
Serotonin 5-HT2C |
88% |
1.288uM |
.674uM |
View
|
| monoamine oxidase A |
PROPARACAINE |
Monoamine Oxidase MAOA |
88% |
1.777uM |
NoneNone |
View
|
| monoamine oxidase A |
PROPARACAINE |
Monoamine Oxidase MAOA |
88% |
1.777uM |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
STANOZOLOL |
CYP450-2C19 Inhibition |
88% |
.048uM |
NoneNone |
View
|
| mu-opioid receptor MOR |
RALOXIFENE |
Opiate mu |
88% |
1.176uM |
.477uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2A |
RALOXIFENE |
Serotonin 5-HT2A |
88% |
1.45uM |
.414uM |
View
|
| acetylcholinesterase (YT blood group) |
RALOXIFENE |
Acetylcholinesterase |
88% |
.4uM |
NoneNone |
View
|
| collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
RALOXIFENE |
Acetylcholinesterase |
88% |
.4uM |
NoneNone |
View
|
| acetylcholinesterase |
RALOXIFENE |
Acetylcholinesterase |
88% |
.4uM |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
TRIBROMSALAN |
Protein Tyrosine Kinase, HER2 Receptor |
88% |
5.97uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
PAROXETINE |
Calcium Channel Type L, Dihydropyridine |
87% |
1.476uM |
.949uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
PERGOLIDE |
Adrenergic alpha2C |
87% |
1.41uM |
.205uM |
View
|
| adrenergic receptor, alpha 2b |
PERGOLIDE |
Adrenergic alpha2C |
87% |
1.41uM |
.205uM |
View
|
| Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
1-(2-METHYLBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
CYP450-2C9 Inhibition |
87% |
1uM |
NoneNone |
View
|
| cytochrome P450, family 2, subfamily C, polypeptide 9 |
1-(2-METHYLBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
CYP450-2C9 Inhibition |
87% |
1uM |
NoneNone |
View
|
| androgen receptor |
HALCINONIDE |
Testosterone |
87% |
.885uM |
.59uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
GUANABENZ |
Serotonin 5-HT1A |
87% |
2.068uM |
1.181uM |
View
|
| adrenergic receptor, beta 1 |
MICONAZOLE |
Adrenergic beta1 |
87% |
12.635uM |
7.296uM |
View
|
| adrenergic, beta-1-, receptor |
MICONAZOLE |
Adrenergic beta1 |
87% |
12.635uM |
7.296uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2B |
ECONAZOLE |
Serotonin 5-HT2B |
87% |
6.833uM |
4.348uM |
View
|
| Cytochrom P450-2C19 monooxygenase |
CLEMASTINE |
CYP450-2C19 Inhibition |
87% |
.6uM |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
CIGLITAZONE |
Adrenergic, Norepinephrine Transporter |
87% |
2.22uM |
2.201uM |
View
|
| cholinergic receptor, muscarinic 2 |
CIGLITAZONE |
Muscarinic M2 |
87% |
21.107uM |
7.505uM |
View
|
| 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
SIMVASTATIN |
HMG-CoA Reductase |
87% |
.00339uM |
NoneNone |
View
|
| 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
SIMVASTATIN |
HMG-CoA Reductase |
87% |
.00339uM |
NoneNone |
View
|
| dopamine receptor D4 |
AURANOFIN |
Dopamine D4.2 |
87% |
1.123uM |
.394uM |
View
|
| adrenergic receptor, alpha 2a |
DIETHYLSTILBESTROL |
Adrenergic alpha2A |
87% |
14.127uM |
5.297uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
DIETHYLSTILBESTROL |
Adrenergic, Norepinephrine Transporter |
87% |
3.67uM |
3.64uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
PHENOTHIAZINE |
Adrenergic, Norepinephrine Transporter |
87% |
.461uM |
.457uM |
View
|
| adrenergic receptor, alpha 2b |
FLUNARIZINE |
Adrenergic alpha2B |
87% |
1.893uM |
.864uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
AMIODARONE |
Serotonin Transporter |
87% |
2.305uM |
1.224uM |
View
|
| androgen receptor |
(R)-BICALUTAMIDE |
Testosterone |
87% |
.801uM |
.534uM |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
YOHIMBINE |
Adrenergic alpha1D |
87% |
1.013uM |
.498uM |
View
|
| synaptic vesicle glycoprotein 2b |
TAZOBACTAM |
beta-Lactamase |
87% |
.299uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 1 polypeptide |
DIGITOXIN |
ATPase, Na+/K+ |
87% |
.225uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 3 polypeptide |
DIGITOXIN |
ATPase, Na+/K+ |
87% |
.225uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, beta 2 polypeptide |
DIGITOXIN |
ATPase, Na+/K+ |
87% |
.225uM |
NoneNone |
View
|
| ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
DIGITOXIN |
ATPase, Na+/K+ |
87% |
.225uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 4 polypeptide |
DIGITOXIN |
ATPase, Na+/K+ |
87% |
.225uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 3 polypeptide |
DIGITOXIN |
ATPase, Na+/K+ |
87% |
.225uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 2 polypeptide |
DIGITOXIN |
ATPase, Na+/K+ |
87% |
.225uM |
NoneNone |
View
|
| ATPase, Na+/K+ transporting, alpha 1 polypeptide |
DIGITOXIN |
ATPase, Na+/K+ |
87% |
.225uM |
NoneNone |
View
|
| histamine receptor H 2 |
DICYCLOMINE |
Histamine H2 |
87% |
1.625uM |
1.598uM |
View
|
| Sigma-2 Receptor |
CISAPRIDE |
Sigma2 |
87% |
.177uM |
.109uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1B |
CARVEDILOL |
Serotonin 5-HT1B |
87% |
1.295uM |
.589uM |
View
|
| mitogen activated protein kinase 14 |
BENZBROMARONE |
Protein Serine/Threonine Kinase, p38alpha |
87% |
1.235uM |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
BENZBROMARONE |
Protein Serine/Threonine Kinase, p38alpha |
87% |
1.235uM |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
BENZOTHIAZYL DISULFIDE |
Serotonin 5-HT1A |
87% |
.747uM |
.427uM |
View
|
| lymphocyte protein tyrosine kinase (mapped) |
TRANS-PLATINUM(II)DIAMMINE DICHLORIDE |
Protein Tyrosine Kinase, Lck |
87% |
2.721uM |
NoneNone |
View
|
| phosphodiesterase 3B |
HEXACHLOROPHENE |
Phosphodiesterase PDE3 |
87% |
1.8505uM |
NoneNone |
View
|
| phosphodiesterase 3A |
HEXACHLOROPHENE |
Phosphodiesterase PDE3 |
87% |
1.8505uM |
NoneNone |
View
|
| Cytochrom P450-2C19 monooxygenase |
THIORIDAZINE |
CYP450-2C19 Inhibition |
87% |
6.3778uM |
NoneNone |
View
|
| A3 adenosine receptor |
SULOCTIDIL |
Adenosine A3 |
87% |
3.7058uM |
2.0946uM |
View
|
| cholinergic receptor, muscarinic 1 |
CINNARIZINE |
Muscarinic M1 |
87% |
2.513uM |
.605uM |
View
|
| arachidonate 15-lipoxygenase, second type |
EPINEPHRINE |
Lipoxygenase 15-LO |
87% |
3.279uM |
NoneNone |
View
|
| arachidonate 15-lipoxygenase |
EPINEPHRINE |
Lipoxygenase 15-LO |
87% |
3.279uM |
NoneNone |
View
|
| arachidonate 15-lipoxygenase |
EPINEPHRINE |
Lipoxygenase 15-LO |
87% |
3.279uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2a |
METHAPYRILENE |
Imidazoline I2, Central |
87% |
1.736uM |
1.157uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
METHAPYRILENE |
Imidazoline I2, Central |
87% |
1.736uM |
1.157uM |
View
|
| histamine receptor H 1 |
DOMPERIDONE |
Histamine H1, Central |
87% |
1.344uM |
.156uM |
View
|
| histamine receptor H 2 |
THIORIDAZINE |
Histamine H2 |
87% |
.95uM |
.934uM |
View
|
| histamine receptor H 2 |
DESLORATADINE |
Histamine H2 |
87% |
1.099uM |
1.08uM |
View
|
| dopamine receptor D3 |
TERFENADINE |
Dopamine D3 |
87% |
1.503uM |
.511uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
CINNARIZINE |
Calcium Channel Type L, Benzothiazepine |
87% |
.823uM |
.732uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
CINNARIZINE |
Calcium Channel Type L, Benzothiazepine |
87% |
.823uM |
.732uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
CINNARIZINE |
Calcium Channel Type L, Benzothiazepine |
87% |
.823uM |
.732uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CLOZAPINE |
Calcium Channel Type L, Benzothiazepine |
86% |
3.752uM |
3.335uM |
View
|
| acetylcholinesterase (YT blood group) |
GALANTAMINE |
Acetylcholinesterase |
86% |
1.156uM |
NoneNone |
View
|
| collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
GALANTAMINE |
Acetylcholinesterase |
86% |
1.156uM |
NoneNone |
View
|
| acetylcholinesterase |
GALANTAMINE |
Acetylcholinesterase |
86% |
1.156uM |
NoneNone |
View
|
| phosphodiesterase 4D |
BENZBROMARONE |
Phosphodiesterase PDE4 |
86% |
1.056uM |
NoneNone |
View
|
| phosphodiesterase 4B, cAMP specific |
BENZBROMARONE |
Phosphodiesterase PDE4 |
86% |
1.056uM |
NoneNone |
View
|
| phosphodiesterase 4A, cAMP specific |
BENZBROMARONE |
Phosphodiesterase PDE4 |
86% |
1.056uM |
NoneNone |
View
|
| phosphodiesterase 4C, cAMP-specific |
BENZBROMARONE |
Phosphodiesterase PDE4 |
86% |
1.056uM |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
CAFFEIC ACID PHENETHYL ESTER |
Protein Serine/Threonine Kinase, ERK2 |
86% |
.686uM |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
CAFFEIC ACID PHENETHYL ESTER |
Protein Serine/Threonine Kinase, ERK2 |
86% |
.686uM |
NoneNone |
View
|
| lymphocyte protein tyrosine kinase (mapped) |
CAFFEIC ACID PHENETHYL ESTER |
Protein Tyrosine Kinase, Lck |
86% |
2.887uM |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
S-(-)-PROPRANOLOL |
Serotonin 5-HT2C |
86% |
1.368uM |
.716uM |
View
|
| carbonic anhydrase 5a, mitochondrial |
TROGLITAZONE |
Carbonic Anhydrase |
86% |
.97uM |
NoneNone |
View
|
| carbonic anhydrase 3 |
TROGLITAZONE |
Carbonic Anhydrase |
86% |
.97uM |
NoneNone |
View
|
| carbonic anhydrase 2 |
TROGLITAZONE |
Carbonic Anhydrase |
86% |
.97uM |
NoneNone |
View
|
| carbonic anhydrase 4 |
TROGLITAZONE |
Carbonic Anhydrase |
86% |
.97uM |
NoneNone |
View
|
| carbonic anhydrase XI |
TROGLITAZONE |
Carbonic Anhydrase |
86% |
.97uM |
NoneNone |
View
|
| carbonic anhydrase IX |
TROGLITAZONE |
Carbonic Anhydrase |
86% |
.97uM |
NoneNone |
View
|
| carbonic anhydrase VIII |
TROGLITAZONE |
Carbonic Anhydrase |
86% |
.97uM |
NoneNone |
View
|
| carbonic anhydrase VII |
TROGLITAZONE |
Carbonic Anhydrase |
86% |
.97uM |
NoneNone |
View
|
| carbonic anhydrase VA, mitochondrial |
TROGLITAZONE |
Carbonic Anhydrase |
86% |
.97uM |
NoneNone |
View
|
| carbonic anhydrase IV |
TROGLITAZONE |
Carbonic Anhydrase |
86% |
.97uM |
NoneNone |
View
|
| carbonic anhydrase III, muscle specific |
TROGLITAZONE |
Carbonic Anhydrase |
86% |
.97uM |
NoneNone |
View
|
| carbonic anhydrase I |
TROGLITAZONE |
Carbonic Anhydrase |
86% |
.97uM |
NoneNone |
View
|
| carbonic anhydrase XIV |
TROGLITAZONE |
Carbonic Anhydrase |
86% |
.97uM |
NoneNone |
View
|
| carbonic anhydrase VB, mitochondrial |
TROGLITAZONE |
Carbonic Anhydrase |
86% |
.97uM |
NoneNone |
View
|
| carbonic anhydrase XII |
TROGLITAZONE |
Carbonic Anhydrase |
86% |
.97uM |
NoneNone |
View
|
| carbonic anhydrase VI |
TROGLITAZONE |
Carbonic Anhydrase |
86% |
.97uM |
NoneNone |
View
|
| carbonic anhydrase II |
TROGLITAZONE |
Carbonic Anhydrase |
86% |
.97uM |
NoneNone |
View
|
| Protein-tyrosine kinase, Fyn |
ECONAZOLE |
Protein Tyrosine Kinase, Fyn |
86% |
12.136uM |
NoneNone |
View
|
| adrenergic receptor, alpha 1d (Non-specific probe) |
ERGOCORNINE |
Adrenergic alpha1D |
86% |
.018uM |
.008747uM |
View
|
| Cytochrom P450-2D6 monooxygenase |
SULCONAZOLE |
CYP450-2D6 Inhibition |
86% |
.8uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
SULCONAZOLE |
Adrenergic alpha2C |
86% |
4.934uM |
.717uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
SULCONAZOLE |
Adrenergic alpha2C |
86% |
4.934uM |
.717uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
DIETHYLSTILBESTROL |
Serotonin Transporter |
86% |
12.492uM |
6.637uM |
View
|
| lymphocyte protein tyrosine kinase (mapped) |
BACITRACIN |
Protein Tyrosine Kinase, Lck |
86% |
1.923uM |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
TIRILAZAD |
Calcium Channel Type L, Phenylalkylamine |
86% |
2.496uM |
2.427uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
TIRILAZAD |
Calcium Channel Type L, Phenylalkylamine |
86% |
2.496uM |
2.427uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
TIRILAZAD |
Calcium Channel Type L, Phenylalkylamine |
86% |
2.496uM |
2.427uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
TIRILAZAD |
Calcium Channel Type L, Phenylalkylamine |
86% |
2.496uM |
2.427uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
TIRILAZAD |
Calcium Channel Type L, Phenylalkylamine |
86% |
2.496uM |
2.427uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
TIRILAZAD |
Calcium Channel Type L, Phenylalkylamine |
86% |
2.496uM |
2.427uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
TIRILAZAD |
Calcium Channel Type L, Phenylalkylamine |
86% |
2.496uM |
2.427uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
TIRILAZAD |
Calcium Channel Type L, Phenylalkylamine |
86% |
2.496uM |
2.427uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
TIRILAZAD |
Calcium Channel Type L, Phenylalkylamine |
86% |
2.496uM |
2.427uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
TIRILAZAD |
Calcium Channel Type L, Phenylalkylamine |
86% |
2.496uM |
2.427uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
TIRILAZAD |
Calcium Channel Type L, Phenylalkylamine |
86% |
2.496uM |
2.427uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
TIRILAZAD |
Calcium Channel Type L, Phenylalkylamine |
86% |
2.496uM |
2.427uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
TIRILAZAD |
Calcium Channel Type L, Phenylalkylamine |
86% |
2.496uM |
2.427uM |
View
|
| phosphodiesterase 3B |
RABEPRAZOLE |
Phosphodiesterase PDE3 |
89% |
2.285uM |
NoneNone |
View
|
| phosphodiesterase 3A |
RABEPRAZOLE |
Phosphodiesterase PDE3 |
89% |
2.285uM |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
BENZETHONIUM CHLORIDE |
Adrenergic alpha2C |
89% |
1.961uM |
.285uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
BENZETHONIUM CHLORIDE |
Adrenergic alpha2C |
89% |
1.961uM |
.285uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
RALOXIFENE |
Calcium Channel Type L, Benzothiazepine |
89% |
.414uM |
.368uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
BENZETHONIUM CHLORIDE |
Serotonin 5-HT2C |
89% |
1.027uM |
.538uM |
View
|
| Sigma-2 Receptor |
ASTEMIZOLE |
Sigma2 |
89% |
.301uM |
.185uM |
View
|
| cholinergic receptor, muscarinic 3 |
CLOMIPHENE |
Muscarinic M3 |
89% |
2.071uM |
.439uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
CLOMIPHENE |
Dopamine Transporter |
89% |
.784uM |
.623uM |
View
|
| adrenergic receptor, alpha 2b |
DROPERIDOL |
Adrenergic alpha2C |
89% |
1.763uM |
.256uM |
View
|
| adrenergic receptor, alpha 2c (Non-specific probe) |
DROPERIDOL |
Adrenergic alpha2C |
89% |
1.763uM |
.256uM |
View
|
| cholinergic receptor, muscarinic 2 |
DIPHENHYDRAMINE |
Muscarinic M2 |
89% |
1.05uM |
.373uM |
View
|
| matrix metalloproteinase 1 (interstitial collagenase) |
DOXAZOSIN |
Protease, Matrix Metalloprotease-1 (MMP-1) |
89% |
5.749uM |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
S-(-)-PROPRANOLOL |
Serotonin Transporter |
89% |
1.241uM |
.659uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
CLEMASTINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.508uM |
.493uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CLEMASTINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.508uM |
.493uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
CLEMASTINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.508uM |
.493uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
CLEMASTINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.508uM |
.493uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
CLEMASTINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.508uM |
.493uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
CLEMASTINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
.508uM |
.493uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
FLUPHENAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
2.534uM |
2.464uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
FLUPHENAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
2.534uM |
2.464uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
FLUPHENAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
2.534uM |
2.464uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
FLUPHENAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
2.534uM |
2.464uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
FLUPHENAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
2.534uM |
2.464uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
FLUPHENAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
2.534uM |
2.464uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
FLUPHENAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
2.534uM |
2.464uM |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
FLUPHENAZINE |
Calcium Channel Type L, Phenylalkylamine |
89% |
2.534uM |
2.464uM |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
TRIBROMSALAN |
Protein Tyrosine Kinase, HER2 Receptor |
88% |
5.97uM |
NoneNone |
View
|
| adenosine A1 receptor |
SB-203580 |
Adenosine A1 |
88% |
2.95uM |
1.721uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
TIBOLONE |
Serotonin Transporter |
88% |
.0907uM |
.0482uM |
View
|
| progesterone receptor |
CLOBETASOL PROPIONATE |
Progesterone |
88% |
.012uM |
.001519uM |
View
|
| progesterone receptor |
CLOBETASOL PROPIONATE |
Progesterone |
88% |
.012uM |
.001519uM |
View
|
| opioid receptor, sigma 1 |
CLOMIPHENE |
Sigma1 |
88% |
.029uM |
.012uM |
View
|
| adrenergic receptor, alpha 2a |
DISULFIRAM |
Adrenergic alpha2A |
88% |
4.904uM |
1.839uM |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Phenylalkylamine |
88% |
.438uM |
.426uM |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Phenylalkylamine |
88% |
.438uM |
.426uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Phenylalkylamine |
88% |
.438uM |
.426uM |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Phenylalkylamine |
88% |
.438uM |
.426uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Phenylalkylamine |
88% |
.438uM |
.426uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Phenylalkylamine |
88% |
.438uM |
.426uM |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Phenylalkylamine |
88% |
.438uM |
.426uM |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Phenylalkylamine |
88% |
.438uM |
.426uM |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Phenylalkylamine |
88% |
.438uM |
.426uM |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
CYPROHEPTADINE |
Calcium Channel Type L, Phenylalkylamine |
88% |
.438uM |
.426uM |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CYPROHEPTADINE |
Calcium Channel Type L, Phenylalkylamine |
88% |
.438uM |
.426uM |
View
|
| 5-hydroxytryptamine (serotonin) receptor 2C |
FENOFIBRATE |
Serotonin 5-HT2C |
88% |
2.371uM |
1.242uM |
View
|
| A3 adenosine receptor |
CIGLITAZONE |
Adenosine A3 |
88% |
3.047uM |
1.722uM |
View
|
| androgen receptor |
BUDESONIDE |
Testosterone |
88% |
1.635uM |
1.09uM |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
DIETHYLSTILBESTROL |
Dopamine Transporter |
88% |
1.071uM |
.851uM |
View
|
| mitogen activated protein kinase 14 |
TANNIC ACID |
Protein Serine/Threonine Kinase, p38alpha |
88% |
.375uM |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
TANNIC ACID |
Protein Serine/Threonine Kinase, p38alpha |
88% |
.375uM |
NoneNone |
View
|
| 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
TANNIC ACID |
HMG-CoA Reductase |
88% |
3.127uM |
NoneNone |
View
|
| 3-hydroxy-3-methylglutaryl-Coenzyme A reductase |
TANNIC ACID |
HMG-CoA Reductase |
88% |
3.127uM |
NoneNone |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
CLOTRIMAZOLE |
Glutamate, NMDA, Agonism |
88% |
13.064uM |
11.82uM |
View
|
| glutamate receptor, ionotropic, NMDA2C |
CLOTRIMAZOLE |
Glutamate, NMDA, Agonism |
88% |
13.064uM |
11.82uM |
View
|
| glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
CLOTRIMAZOLE |
Glutamate, NMDA, Agonism |
88% |
13.064uM |
11.82uM |
View
|